{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(1)"],"submitter":["Oh KK"],"funding":["The Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology","Korea Institute for Advancement of Technology funded by the Ministry of Trade, Industry and Energy","Bio Industrial Technology Development Program funded by the Ministry of Trade, Industry and Energy","Hallym University Research Fund","Korea Institute for Advancement of Technology funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea)","Bio Industrial Technology Development Program funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea)"],"journal":["Journal of translational medicine"],"pagination":["262"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10926570"],"repository":["biostudies-literature"],"pubmed_title":["A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology."],"pmcid":["PMC10926570"],"funding_grant_id":["P0020622","NRF-2020R1A6A1A03043026","NRF2019R1I1A3A01060447","20018494"],"pubmed_authors":["Yoon SJ","Kim DJ","Kwon GH","Suk KT","Eom JA","Lee KJ","Oh KK"],"additional_accession":[]},"is_claimable":false,"name":"A strategy to pioneer key agent(s) in Cephalotaxus alkaloids against pan-cancer via filtering methodology based on integrated pharmacology.","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2025-04-22T16:20:16.493Z","creation":"2024-12-04T09:28:37.619Z"},"accession":"S-EPMC10926570","cross_references":{"pubmed":["38462631"],"doi":["10.1186/s12967-024-05059-0"]}}